Botanix Pharmaceuticals Limited announced the appointment of Daniel Sharp, to the Botanix Board of Directors as a Non-Executive Director. He is currently a Non-Executive Director of health informatics company Alcidion Group Ltd.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.325 AUD | +3.17% |
|
-13.33% | +71.05% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+71.05% | 379M | |
+4.09% | 70.89B | |
+16.90% | 9.08B | |
+11.92% | 4.53B | |
-21.91% | 4.47B | |
+22.70% | 3.97B | |
+2.19% | 2.08B | |
+11.95% | 2.04B | |
-36.00% | 1.94B | |
-45.17% | 1.77B |
- Stock Market
- Equities
- BOT Stock
- News Botanix Pharmaceuticals Limited
- Botanix Pharmaceuticals Limited Appoints Daniel Sharp as Non-Executive Director